Bank of America’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$118M Sell
1,452,277
-434,564
-23% -$31.4M 0.01% 1069
2026
Q1
$129M Buy
1,886,841
+455,284
+32% +$32.2M 0.01% 956
2025
Q4
$109M Sell
1,431,557
-85,479
-6% -$6.21M 0.01% 1054
2025
Q3
$93.1M Buy
1,517,036
+135,628
+10% +$7.06M 0.01% 1255
2025
Q2
$67.5M Buy
1,381,408
+865,281
+168% +$41.1M ﹤0.01% 1462
2025
Q1
$26.3M Buy
516,127
+259,591
+101% +$13M ﹤0.01% 2166
2024
Q4
$11.6M Sell
256,536
-58,187
-18% -$2.49M ﹤0.01% 2799
2024
Q3
$11.7M Buy
314,723
+3,860
+1% +$129K ﹤0.01% 2921
2024
Q2
$9.51M Sell
310,863
-72,834
-19% -$2.36M ﹤0.01% 2999
2024
Q1
$11.2M Buy
383,697
+117,758
+44% +$3.3M ﹤0.01% 2886
2023
Q4
$7.33M Sell
265,939
-113,229
-30% -$2.59M ﹤0.01% 3214
2023
Q3
$8.5M Sell
379,168
-78,121
-17% -$2.91M ﹤0.01% 2885
2023
Q2
$18.6M Buy
457,289
+10,925
+2% +$535K ﹤0.01% 2115
2023
Q1
$21.6M Buy
446,364
+66,344
+17% +$3.03M ﹤0.01% 2047
2022
Q4
$14.5M Buy
380,020
+40,457
+12% +$1.68M ﹤0.01% 2315
2022
Q3
$17M Sell
339,563
-17,714
-5% -$868K ﹤0.01% 2101
2022
Q2
$14.3M Buy
357,277
+71,482
+25% +$2.51M ﹤0.01% 2315
2022
Q1
$10.7M Sell
285,795
-2,348,348
-89% -$90.5M ﹤0.01% 2803
2021
Q4
$105M Buy
2,634,143
+2,352,106
+834% +$90M 0.01% 968
2021
Q3
$10.5M Sell
282,037
-5,606
-2% -$230K ﹤0.01% 2800
2021
Q2
$12.2M Sell
287,643
-75,067
-21% -$3.22M ﹤0.01% 2630
2021
Q1
$17.2M Buy
362,710
+24,381
+7% +$1.45M ﹤0.01% 2173
2020
Q4
$20.6M Sell
338,329
-60,457
-15% -$3.56M ﹤0.01% 1858
2020
Q3
$18.6M Buy
398,786
+129,655
+48% +$6.38M ﹤0.01% 1763
2020
Q2
$13.7M Buy
269,131
+32,901
+14% +$1.62M ﹤0.01% 1945
2020
Q1
$10.5M Buy
236,230
+11,008
+5% +$554K ﹤0.01% 2023
2019
Q4
$10.8M Sell
225,222
-43,282
-16% -$1.84M ﹤0.01% 2479
2019
Q3
$9.08M Sell
268,504
-97,427
-27% -$4.24M ﹤0.01% 2606
2019
Q2
$16.5M Buy
365,931
+90,386
+33% +$3.57M ﹤0.01% 2046
2019
Q1
$10.4M Buy
275,545
+89,613
+48% +$3.01M ﹤0.01% 2450
2018
Q4
$6.38M Buy
185,932
+11,878
+7% +$427K ﹤0.01% 2741
2018
Q3
$8.18M Sell
174,054
-58,714
-25% -$2.43M ﹤0.01% 2688
2018
Q2
$7.85M Buy
232,768
+35,017
+18% +$1.09M ﹤0.01% 2701
2018
Q1
$5.35M Sell
197,751
-366,575
-65% -$9.29M ﹤0.01% 3017
2017
Q4
$9.41M Buy
564,326
+181,192
+47% +$3.07M ﹤0.01% 2507
2017
Q3
$7.67M Sell
383,134
-28,499
-7% -$558K ﹤0.01% 2775
2017
Q2
$7.54M Sell
411,633
-65,489
-14% -$882K ﹤0.01% 2649
2017
Q1
$4.7M Sell
477,122
-46,901
-9% -$568K ﹤0.01% 3091
2016
Q4
$5.72M Buy
524,023
+30,083
+6% +$316K ﹤0.01% 2805
2016
Q3
$6.92M Sell
493,940
-9,179
-2% -$74.6K ﹤0.01% 2550
2016
Q2
$3.53M Buy
503,119
+186,125
+59% +$1.37M ﹤0.01% 3108
2016
Q1
$2.04M Buy
316,994
+23,907
+8% +$415K ﹤0.01% 3545
2015
Q4
$9.5M Sell
293,087
-3,903
-1% -$115K ﹤0.01% 2301
2015
Q3
$7.93M Buy
296,990
+186,590
+169% +$7.98M ﹤0.01% 2427
2015
Q2
$5.31M Buy
110,400
+73,065
+196% +$4.26M ﹤0.01% 2531
2015
Q1
$2.27M Buy
37,335
+28,815
+338% +$1.76M ﹤0.01% 3136
2014
Q4
$441K Buy
8,520
+2,227
+35% +$98K ﹤0.01% 4730
2014
Q3
$277K Sell
6,293
-3,634
-37% -$114K ﹤0.01% 5087
2014
Q2
$259K Buy
9,927
+9,905
+45,023% +$212K ﹤0.01% 5312
2014
Q1
$1K Sell
22
-1,725
-99% -$46.4K ﹤0.01% 7640
2013
Q4
$30K Buy
+1,747
New +$30.7K ﹤0.01% 6843

Other funds holding PTCT

Bank of America's PTCT Position: Q2 2026 in Review

Bank of America reduced its PTC Therapeutics (PTCT) stake by 23% in Q2 2026, selling an estimated $31.4M and leaving 1,452,277 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #1069.

Bank of America first reported a position in PTCT in Q4 2013 and has held it in 51 quarters since. The position peaked at $129M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Bank of America held 1,452,277 shares of PTC Therapeutics worth $118M as of Q2 2026.
  • Bank of America sold 434,564 PTC Therapeutics shares in Q2 2026, an estimated $31.4M.
  • PTC Therapeutics made up 0.01% of Bank of America's portfolio in Q2 2026, its #1069 holding.
  • Bank of America first reported a position in PTC Therapeutics in Q4 2013 and has held it in 51 quarters since.
  • Bank of America's PTC Therapeutics position peaked at $129M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.